Varian Medical Systems
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Varian Medical Systems generated cash of $785,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$93,000,000 last year. Net change in cash is therefore $241,000,000.
Cash Flow
| 2011 | 472.77M | -117.93M | -311.33M |
|---|---|---|---|
| 2012 | 492.8M | -122.3M | -234.7M |
| 2013 | 455.2M | -96.3M | 51.6M |
| 2014 | 449M | -133.1M | -595.5M |
| 2015 | 469.55M | -210.91M | -276.68M |
| 2016 | 356.3M | -109.2M | -245.8M |
| 2017 | 399.1M | -130.1M | -392.4M |
| 2018 | 454.9M | -174.7M | -487M |
| 2019 | 371.8M | -631.7M | 279.2M |
| 2020 | 785M | -140M | -93M |
VAR Cash Flow Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 544M | 504.8M | 716.2M | 811.4M | 845.5M | 849.3M | 1.11B | 704.6M | 564.5M | 520.22M |
Operating activities | ||||||||||
Net income | 0 | 291.9M | 149.9M | 218.5M | 402.3M | 411.5M | 403.7M | 438.2M | 427M | 398.93M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 60M | 93M | 72.7M | 76.9M | 79.8M | 68.52M | 62.5M | 62.8M | 61M | 52.59M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42.63M | 47.87M | 42.01M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42.63M | 47.87M | 42.01M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 35M | -111.7M | -76.1M | -52.6M | -168.3M | -79.39M | -74.50M | -43.30M | -87.43M | -41.57M |
Inventories | 38M | -106.9M | -16.4M | -100K | -27.7M | -41.55M | -43.34M | -76.4M | -42.45M | -42.23M |
Accounts payable | -66M | 49.7M | 21.9M | 5.5M | 9.7M | 6.46M | 1.97M | 7.78M | 19.27M | 35.52M |
Cash generated by operating activities | 785M | 371.8M | 454.9M | 399.1M | 356.3M | 469.55M | 449M | 455.2M | 492.8M | 472.77M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -199.5M | -199.7M | -316.3M | -3.3M | -423.79M | -672.95M | -429.97M | -257.44M | -32.80M |
Investments In Property Plant And Equipment | -84M | -58M | -47.7M | -59.1M | -80.4M | -91.38M | -89.64M | -76.27M | -61.10M | -70.92M |
Acquisitions Net | -36M | -576.2M | -109M | -3M | -21M | -95.30M | -31.5M | 0 | -28.24M | -9M |
Cash generated by investing activities | -140M | -631.7M | -174.7M | -130.1M | -109.2M | -210.91M | -133.1M | -96.3M | -122.3M | -117.93M |
Financing activities | ||||||||||
Common Stock Issued | 76M | 63M | 60M | 72M | 60.6M | 90.97B | 99.65B | 129.58B | 60.33B | 137.69M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -86M | -103.3M | -121.2M | -222.4M | -461.3M | -331.05M | -528.1M | -290.4M | -197.1M | -505.28M |
Repayments of term debt | 0 | 0 | -503.3M | 0 | -133M | 0 | -68.75M | 0 | -9.87M | -7.26M |
Cash used in financing activities | -93M | 279.2M | -487M | -392.4M | -245.8M | -276.68M | -595.5M | 51.6M | -234.7M | -311.33M |
Net Change In Cash | 241M | 27.7M | -202.1M | -127.3M | -2M | -3.80M | -268.6M | 413.3M | 140.1M | 44.23M |
Cash at end of period | 785M | 532.5M | 514.1M | 684.1M | 843.5M | 845.49M | 849.3M | 1.11B | 704.6M | 564.45M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |